Horizon Therapeutics (NASDAQ:HZNP) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Horizon Therapeutics beat estimated earnings by 11.67%, reporting an EPS of $1.34 versus an estimate of $1.2.
Revenue was up $542.84 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 1.28% increase in the share price the next day.
Here's a look at Horizon Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.34 | 1.54 | 0.88 | 0.04 |
| EPS Actual | 1.41 | 1.75 | 1.62 | 0.03 |
| Revenue Estimate | 995.87M | 979.41M | 685.03M | 330.73M |
| Revenue Actual | 1.01B | 1.04B | 832.55M | 342.41M |
To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
